Gotham Asset Management LLC Grows Stock Holdings in LivaNova PLC (NASDAQ:LIVN)

Gotham Asset Management LLC increased its stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 206.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,219 shares of the company's stock after acquiring an additional 18,338 shares during the quarter. Gotham Asset Management LLC owned about 0.05% of LivaNova worth $1,261,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of LIVN. Russell Investments Group Ltd. lifted its stake in LivaNova by 17.1% in the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after buying an additional 219 shares during the last quarter. Sterling Capital Management LLC increased its holdings in shares of LivaNova by 800.6% in the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock valued at $75,000 after acquiring an additional 1,441 shares during the period. Vestcor Inc purchased a new stake in LivaNova in the 4th quarter valued at $204,000. Optimize Financial Inc purchased a new stake in LivaNova in the 4th quarter valued at $208,000. Finally, Corton Capital Inc. acquired a new stake in LivaNova during the 4th quarter worth $214,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on LIVN shares. Wall Street Zen lowered shares of LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. Wolfe Research raised LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price target on the stock in a report on Tuesday. Stifel Nicolaus reduced their price objective on LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a research note on Wednesday, February 26th. Mizuho decreased their price objective on LivaNova from $70.00 to $60.00 and set an "outperform" rating for the company in a research report on Wednesday, February 26th. Finally, The Goldman Sachs Group lowered their target price on LivaNova from $64.00 to $55.00 and set a "buy" rating on the stock in a research note on Monday, March 3rd. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $59.29.

LivaNova Price Performance

Shares of LivaNova stock traded down $0.79 during trading on Thursday, reaching $42.88. The company's stock had a trading volume of 75,412 shares, compared to its average volume of 645,718. The business has a 50 day moving average price of $38.70 and a 200-day moving average price of $44.75. LivaNova PLC has a 12-month low of $32.48 and a 12-month high of $61.94. The company has a market capitalization of $2.34 billion, a P/E ratio of 102.10 and a beta of 0.84. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.